Comment on "Type 1 receptor tyrosine kinase profiles identify patients with enhanced benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial". [J Clin Oncol. 2008]
Anthracyclines: the first generation of cytotoxic targeted agents? A possible dream / Di Leo A; Moretti E. - In: JOURNAL OF CLINICAL ONCOLOGY. - ISSN 0732-183X. - ELETTRONICO. - (2008), pp. 5011-5013.
Anthracyclines: the first generation of cytotoxic targeted agents? A possible dream
MORETTI, ERICA
2008
Abstract
Comment on "Type 1 receptor tyrosine kinase profiles identify patients with enhanced benefit from anthracyclines in the BR9601 adjuvant breast cancer chemotherapy trial". [J Clin Oncol. 2008]
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
